PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myeloma

PD-L1 expressed on tumor cells contributes to disease progression with evasion from tumor immunity. Plasma cells from multiple myeloma (MM) patients expressed higher levels of PD-L1 compared with healthy volunteers and monoclonal gammopathy of undetermined significance (MGUS) patients, and its expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Hideto, Ishibashi, Mariko, Sunakawa-Kii, Mika, Inokuchi, Koiti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226506/
https://www.ncbi.nlm.nih.gov/pubmed/32290052
http://dx.doi.org/10.3390/cancers12040924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226506/
https://www.ncbi.nlm.nih.gov/pubmed/32290052
http://dx.doi.org/10.3390/cancers12040924

Ejemplares similares